Chemical Compound

1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-; 1,3-Dioxole, 1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid deriv.; 6-Fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid; (+/-)-7-[4-[(Z)-2,3-Dihydroxy-2-butenyl]-1-piperazinyl]-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid, cyclic carbonate; NM 441; Prulifloxacin; Quisnon; Sword

Brand: EASY CDMO
SKU: 65947

CAS Registry Number 123447-62-1

返回搜索申请报价

Primary record

1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-; 1,3-Dioxole, 1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid deriv.; 6-Fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid; (+/-)-7-[4-[(Z)-2,3-Dihydroxy-2-butenyl]-1-piperazinyl]-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid, cyclic carbonate; NM 441; Prulifloxacin; Quisnon; Sword

库存: 5,444 克
纯度: 99.7 %
CAS: 123447-62-1

化合物标识与属性

CAS: 123447-62-1
PubChem CID: 65947
SMILES: CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C
Canonical SMILES: Cc1oc(=O)oc1CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)c2n3C(C)S2)CC1

名称与同义词

Prulifloxacin
Pruvel
123447-62-1
Quisnon
Sword
prulifloxacine
prulifloxacino
prulifloxacinum
NM441
Prulifloxacin [INN]
Pufloxacin dioxolil
NM-441
Prulifloxacin (Pruvel)
C21H20FN3O6S
NM 441
PRULIFLOXACIN 1G
PRULIFLOXACIN 5G
DTXSID0046480
Prulifloxacin (Standard)
RefChem:176763
CCRIS 7686
J42298IESW
UNII-J42298IESW
Prulifloxacin (hydrochloride)
PRULIFLOXACIN [MI]
PRULIFLOXACIN [JAN]
AC1L24AZ
AC1Q6H3L
2-iodo-1,4-benzenediamine
DTXCID8026480
MLS006011767
PRULIFLOXACIN [MART.]
MFCD00864847
PRULIFLOXACIN [WHO-DD]
PWNMXPDKBYZCOO-UHFFFAOYSA-N
CHEMBL422648
NAD-441A
OPT-99
orb1301827
SCHEMBL1650794
NSC-759833
SCHEMBL29540773
C22H22FN3O6
CHEBI:32071
GTPL12860
HY-B0024R
KS-00000GZP
AOB5600
J01MA17
MSK5749
GLXC-06577
HMS5080A06
BCP12727
CID65947
HY-B0024
Tox21_112235
BBL034010
CID:65947
NCGC00164615-01
s2071
STK626148
AKOS005559236
C21-H20-F-N3-O6-S
NM441;AF 3013
Prulifloxacin (NM441, AF 3013)
Tox21_112235_1
AC-2012
ACN-039935
AN-5553
AP27249
CS-2950
CS-O-30718
DB11892
NSC 759833
SB18983
NCGC00164615-02
NCGC00164615-03
Prulifloxacin 100 microg/mL in Acetonitrile
5-(Chlorosulfonyl)-2-Hydroxybenzoic Acid
6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
AK144730
AS-13607
BC208945
I926
SC-88499
SID:53788824
SMR000046722
6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
AB0013936
AB2000475
J561.792H
LS-150467
CAS-123447-62-1
FT-0651733
NS00068018
P2058
ST24045357
F20576
K-1771
SBI-0653843.0001
447P621
A805077
C074191
Prulifloxacin, >=98% (perchloric acid titration)
SR-01000872596
1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-
I06-0209
I06-1868
Q3924793
SR-01000872596-1
BRD-A92341659-001-01-6
BRD-A92341659-001-03-2
BRD-A92341659-001-04-0
Prulifloxacin =98.0% (by HPLC, titration analysis)
1H,4H-(1,3)Thiazeto(3,2-a)quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1-piperazinyl)-4-oxo-
123447-63-2
6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
(+-)-7-(4-((Z)-2,3-Dihydroxy-2-butenyl)-1-piperazinyl)-6-fluoro-1-methyl-4-oxo-1H,4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid, cyclic carbonate
6-fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxelen-4-yl)methyl-1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid
6-FLUORO-1-METHYL-7-{4-[(5-METHYL-2-OXO-2H-1,3-DIOXOL-4-YL)METHYL]PIPERAZIN-1-YL}-4-OXO-1H,4H-[1,3]THIAZETO[3,2-A]QUINOLINE-3-CARBOXYLIC ACID
(RS)-6-Fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid
1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-; 1,3-Dioxole, 1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid deriv.; 6-Fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid; (+/-)-7-[4-[(Z)-2,3-Dihydroxy-2-butenyl]-1-piperazinyl]-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid, cyclic carbonate; NM 441; Prulifloxacin; Quisnon; Sword
6-Fluoro-1-methyl-7-[4-(5-methyl-2-oxo-1,3-dioxol-4-yl)methylpiperazin-1-yl]-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
6-Fluoro-1-methyl-7-[4-(5-methyl-2-oxo-1,3-dioxole-4-ylmethyl)-1-piperazinyl]-4-oxo-4H-[1,3]thiazete[3,2-a]quinoline-3-carboxylic acid
6-Fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-carboxylic Acid
6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-4-ium-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
6-fluoro-1-methyl-7-{4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl}-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
6-Fluoro-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-1-methyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid